000 03612nam a2200373 i 4500
001 vtls000102826
003 KUKTEM
005 20251117113348.0
008 180122s2017 my a f am 000 0 eng d
020 _aTHE0000939(Local)
039 9 _a201905271032
_bnazirah
_c201802201220
_dsaini
_y201801221404
_zsaini
040 _aUMP
_beng
_cUMP
_erda
090 _aFKKSA .L54 2017 r Bc.
100 1 _aLiew, Hui Ching,
_eauthor.
245 1 0 _aDevelopment and characterization of dual modality system using polymeric nanocarrier /
_cLiew Hui Ching
264 1 _aKuantan, Pahang :
_bUMP,
_c2017
264 4 _c© 2017
300 _axiii, 45 pages :
_billustrations (some color) ;
_c30 cm. +
_e1 CD-ROM
336 _atext
_2rdacontent
336 _atext
_2rdacontent
337 _aunmediated
_2rdamedia
337 _acomputer
_2rdamedia
338 _avolume
_2rdacarrier
338 _acomputer dics
_2rdacarrier
347 _atext file
_bPDF
_2rda
500 _aFaculty of Chemical & Natural Resources Engineering
502 _aProject Paper (Bachelor of Chemical Engineering) -- Universiti Malaysia Pahang – 2017
504 _aIncludes bibliographical references
520 3 _aTheranostic micelles and polymeric nanocarrier-based drug delivery system are two fields that have shown significant commitment in cancer treatment. Co-delivery of therapeutic and diagnostic agent in polymeric micelles for combination of therapy and diagnosis able to detect cancer cell in early stage, increase killing effect and suppress multidrug resistance (MDS) for better therapeutic effectiveness. Biocompatible and biodegradable polymeric nanocarriers generally have higher stability, sustained and controllable drug-release profiles and higher loading capacity for hydrophobic (poorly water soluble) drugs. Therefore, the aim of this study is to develop a dual modality micellar system using D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) as nanocarrier for co-delivery of docetaxel as a model chemotherapeutic drug and coumarin-6 as a model fluorescence imaging agent for simultaneous cancer imaging and therapy in early stage. The theranostic micelles were prepared by solvent casting method and characterize for their particle size, drug loading, drug encapsulation efficiency and in vitro drug release profile. This dual modality micellar system was successfully developed with average particle size of 79.59 nm in diameter and drug loading up to 15.46 μg/mg (encapsulation efficiency of 78.99%) and 9.83 μg/mg (encapsulation efficiency of 36.20%) for docetaxel and coumarin-6 respectively. Besides, the in vitro drug release profile of the micelles revealed a desired sustained and controlled drug release manner for both docetaxel and coumarin-6. In conclusion, the micelles size obtained is in favourable range for passive targeting through enhanced permeability and retention (EPR) effect and the drug loading and encapsulation efficiency attained are adequate for therapy and diagnosis purposes on cancer cells. The sustained drug release also beneficial in lower drug administration. This dual modality system is taking great advantages for tumour imaging and inhibition of tumour growth which is very important for early cancer detection, thereby having efficiency therapy on cancer cells.
610 2 0 _aFaculty of Chemical & Natural Resources Engineering
_xDissertations
650 0 _aUniversities and Colleges
_xDissertations
650 0 _aTheses
999 _aVIRTUA40
_c7362
_d7368
999 _aVTLSSORT0080*0200*0400*0900*1000*2450*2640*2641*3000*3360*3361*3370*3371*3380*3381*3470*5000*5020*5040*5200*6100*6500*6501*9992